Signia Therapeutics is an innovative French start-up company.
Signia Therapeutics has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in January 2022.
Signia Therapeutics's investors include Bpifrance, EISMEA, Neovacs.
Signia Therapeutics is headquartered in Lyon, France.
Signia Therapeutics is an innovative French start-up company.
Signia Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Signia Therapeutics — Funding & Investors." VCBacked, January 4, 2022, https://www.vcbacked.co/company/signia-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Signia Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/signia-therapeutics
{{cite web |title=Signia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/signia-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated